Testicular intraepithelial neoplasia (TIN; so-called carcinoma in situ
of the testis) is the uniform precursor of testicular germ-cell tumor
s. TIN is derived from embryonal gonocytes and is present in the testi
s of a future testis cancer patient at the time of birth. TIN spreads
inside the seminiferous tubules until it progresses to invasive cancer
. Diagnosis is best achieved by surgical biopsy of the testis and subs
equent immunohistological staining of placental alkaline phosphatase.
This enzyme is present in gonocytes, TIN, and seminoma as well as in s
everal other types of germ-cell tumors but not in normal germ cells. T
IN is found in testicular tissue adjacent to testicular germ-cell tumo
rs and is observed in all clinical groups known to be at risk for test
icular cancer: cryptorchidism (2-3%), infertility (1%), ambiguous geni
talia (25%), in contralateral testis of patients with testis cancer (3
-6%). Conversely, TIN is not found in the normal male population. If T
IN is left untreated, there is a 50% probability of progressing to fra
nk germ-cell neoplasm within 5 years. Localized radiotherapy to the te
stis with 18-20 Gy eradicates TIN and germ cells while Leydig cells ar
e preserved. The patient can thus be spared orchiectomy and hormone su
pplementation. The concept of TIN offers the chance of very early dete
ction of testis cancer and organ-preserving early treatment.